Compare iShares MSCI Indonesia ETF (EIDO) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Indonesia ETF vs GeneDx Holdings Corp — how do they compare? iShares MSCI Indonesia ETF trades at $11.89 (market cap $409.22M), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: GeneDx Holdings Corp is far larger — about 4.9× iShares MSCI Indonesia ETF's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, iShares MSCI Indonesia ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Indonesia ETF for 76 Days and GeneDx Holdings Corp for 19 Days on average.
| EIDO | WGS | |
|---|---|---|
Market Cap | $409.22M | $2.02B |
Volume | 879,527 | 734,640 |
52-Week High | $19.22 | $167.51 |
52-Week Low | $10.80 | $34.51 |
Typical Hold Time | 76 Days | 19 Days |
Sector | — | Health |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EIDO (iShares MSCI Indonesia ETF) trades at $11.67, down 1.6% with bearish technical signals from moving averages and mixed oscillators. The ETF faces weak price action despite a low P/E ratio of 8.7x, with heavy financial sector exposure (44%) limiting growth potential. Recent news highlights foreign capital outflows from Asian markets and Indonesia's failure to benefit from commodity gains, contributing to negative sentiment.
The outlook remains cautious with technical downtrends and structural growth constraints. Investment opportunity lies in valuation discount, but risks include sector concentration and regional capital rotation. Upside depends on improved foreign inflows and commodity-driven economic momentum.
GeneDx (WGS) trades at $67.73, down 1.17% today, showing mixed signals with bearish technical indicators but strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating expectations, and returned to adjusted profitability early. However, 2026 fundamentals show concerning trends with a net loss of $106 million and negative profit margins. Recent news highlights product innovations and leadership recognition, while technical analysis indicates the stock is trading near key support at $66.
The investment outlook presents a dichotomy between strong analyst conviction (90.9% buy ratings, $81 consensus target) and challenging fundamentals. While operational improvements and genomic testing growth offer potential upside, persistent losses and negative cash flow trends create significant execution risk. The stock's current position near support levels combined with oversold RSI readings suggests potential for near-term bounce, but sustainable gains require meaningful profitability improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About iShares MSCI Indonesia ETF
The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The index is a free float-adjusted market capitalization-weighted index that is designed to measure the performance of the large-, mid- and small-capitalization segments of the equity market in Indonesia. The fund is non-diversified.
Read more on EIDO →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
